SSX3

Across TCGA pan-cancer cohorts, SSX3 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SSX3 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SSX3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SSX3 expression acts as an unfavorable survival marker.

LUAD and STAD are the cancer types where SSX3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.300	0.686	.003	15	view →
STAD	OS	Median	III,IV	0.003	0.633	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SSX3–LUAD (OS)

Open the LUAD breakdown →